• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项在小型基层医疗实践中推广和实施心血管风险降低策略的对照试验。

A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices.

机构信息

The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Division of General Internal Medicine and Clinical Epidemiology, The University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

出版信息

Health Serv Res. 2020 Dec;55(6):944-953. doi: 10.1111/1475-6773.13571. Epub 2020 Oct 13.

DOI:10.1111/1475-6773.13571
PMID:33047340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7704467/
Abstract

OBJECTIVE

To assess the effect of dissemination and implementation of an intervention consisting of practice facilitation and a risk-stratified, population management dashboard on cardiovascular risk reduction for patients at high risk in small, primary care practices.

STUDY SETTING

A total of 219 small primary care practices (≤10 clinicians per site) across North Carolina with primary data collection from electronic health records (EHRs) from the fourth quarter of 2015 through the second quarter of 2018.

STUDY DESIGN

We performed a stepped-wedge, stratified, cluster randomized trial of a one-year intervention consisting of practice facilitation utilizing quality improvement techniques coupled with a cardiovascular dashboard that included lists of risk-stratified adults, aged 40-79 years and their unmet treatment opportunities. The primary outcome was change in 10-Year ASCVD Risk score among all patients with a baseline score ≥10 percent from baseline to 3 months postintervention.

DATA COLLECTION/ EXTRACTION METHODS: Data extracts were securely transferred from practices on a nightly basis from their EHR to the research team registry.

PRINCIPLE FINDINGS

ASCVD risk scores were assessed on 437 556 patients and 146 826 had a calculated 10-year risk ≥10 percent. The mean baseline risk was 23.4 percent (SD ± 12.6 percent). Postintervention, the absolute risk reduction was 6.3 percent (95% CI 6.3, 6.4). Models considering calendar time and stepped-wedge controls revealed most of the improvement (4.0 of 6.3 percent) was attributable to the intervention and not secular trends. In multivariate analysis, male gender, age >65 years, low-income (<$40 000), and Black race (P < .001 for all variables) were each associated with greater risk reductions.

CONCLUSION

A risk-stratified, population management dashboard combined with practice facilitation led to substantial reductions of 10-year ASCVD risk for patients at high risk. Similar approaches could lead to effective dissemination and implementation of other new evidence, especially in rural and other under-resourced practices. Registration: ClinicalTrials.Gov 15-0479.

摘要

目的

评估一项干预措施的传播和实施效果,该措施包括实践促进以及基于风险分层的人群管理仪表板,以降低高危小型基层医疗实践中的患者的心血管风险。

研究场所

北卡罗来纳州共有 219 家小型基层医疗实践(每个站点≤10 名临床医生),主要数据来自 2015 年第四季度至 2018 年第二季度的电子健康记录(EHR)。

研究设计

我们进行了一项为期一年的干预措施的分步楔形、分层、聚类随机试验,该干预措施包括利用质量改进技术进行实践促进,以及一个心血管仪表板,其中包括按风险分层的 40-79 岁成年人列表,以及他们未得到满足的治疗机会。主要结局是所有基线评分≥10%的患者在基线至干预后 3 个月期间的 10 年 ASCVD 风险评分的变化。

数据收集/提取方法:每晚,数据从实践中安全地从他们的 EHR 传输到研究团队的注册中心。

主要发现

对 437556 名患者进行了 ASCVD 风险评分评估,其中 146826 名患者的 10 年风险≥10%。平均基线风险为 23.4%(标准差±12.6%)。干预后,绝对风险降低了 6.3%(95%CI 6.3,6.4)。考虑日历时间和分步楔形控制的模型表明,大部分改善(6.3%的 4.0)归因于干预,而不是时间推移趋势。在多变量分析中,男性、年龄>65 岁、低收入(<$40000)和黑人种族(所有变量 P<0.001)均与更大的风险降低相关。

结论

基于风险分层的人群管理仪表板与实践促进相结合,为高危患者的 10 年 ASCVD 风险带来了实质性降低。类似的方法可以有效地传播和实施其他新证据,特别是在农村和其他资源不足的实践中。注册:ClinicalTrials.Gov 15-0479。

相似文献

1
A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices.一项在小型基层医疗实践中推广和实施心血管风险降低策略的对照试验。
Health Serv Res. 2020 Dec;55(6):944-953. doi: 10.1111/1475-6773.13571. Epub 2020 Oct 13.
2
Advancing heart health in North Carolina primary care: the Heart Health NOW study protocol.改善北卡罗来纳州初级保健中的心脏健康:“现在就关注心脏健康”研究方案
Implement Sci. 2015 Nov 14;10:160. doi: 10.1186/s13012-015-0348-4.
3
A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care.一项关于实践促进以改善心血管护理的真实世界阶梯楔形整群随机试验。
Implement Sci. 2015 Oct 28;10:150. doi: 10.1186/s13012-015-0341-y.
4
Practice facilitation for improving cardiovascular care: secondary evaluation of a stepped wedge cluster randomized controlled trial using population-based administrative data.改善心血管护理的实践促进:使用基于人群的行政数据对阶梯楔形整群随机对照试验的二次评估
Trials. 2016 Sep 5;17(1):434. doi: 10.1186/s13063-016-1547-2.
5
Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma.采用阶梯楔形设计传播、实施和评估以患者为中心的结果以改善心血管护理:俄克拉荷马州的健康心脏计划
BMC Health Serv Res. 2018 Jun 4;18(1):404. doi: 10.1186/s12913-018-3189-4.
6
The design and conduct of Project RedDE: A cluster-randomized trial to reduce diagnostic errors in pediatric primary care.“红色DE项目”的设计与实施:一项旨在减少儿科初级保健中诊断错误的整群随机试验。
Clin Trials. 2019 Apr;16(2):154-164. doi: 10.1177/1740774518820522. Epub 2019 Feb 5.
7
Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care.通过外展促进提高心血管护理的提供(IDOCC):初级保健中一项群组随机对照试验的研究方案和实施细节。
Implement Sci. 2011 Sep 27;6:110. doi: 10.1186/1748-5908-6-110.
8
9
The Tennessee Heart Health Network effectiveness study: A stepped wedge cluster randomized controlled trial to assess the effectiveness of statewide quality improvement cooperative participation on cardiovascular outcomes.田纳西心脏健康网络有效性研究:一项阶梯式楔形整群随机对照试验,旨在评估全州质量改进合作参与对心血管结局的有效性。
Contemp Clin Trials. 2024 Sep;144:107616. doi: 10.1016/j.cct.2024.107616. Epub 2024 Jul 4.
10
The STUN (STop UNhealthy) Alcohol Use Now trial: study protocol for an adaptive randomized trial on dissemination and implementation of screening and management of unhealthy alcohol use in primary care.STUN(立即停止不健康饮酒)试验:一项关于在初级保健中推广和实施筛查及管理不健康饮酒的适应性随机试验的研究方案。
Trials. 2021 Nov 16;22(1):810. doi: 10.1186/s13063-021-05641-7.

引用本文的文献

1
Healthcare dashboard technologies and data visualization for lipid management: A scoping review.用于脂质管理的医疗保健仪表板技术和数据可视化:范围综述。
BMC Med Inform Decis Mak. 2024 Nov 21;24(1):352. doi: 10.1186/s12911-024-02730-w.
2
Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease.宾夕法尼亚医药健康心脏研究的设计与原理:一项针对动脉粥样硬化性心血管疾病高危患者血压和胆固醇改善的中心组织方法有效性的随机试验。
Am Heart J. 2024 Dec;278:208-222. doi: 10.1016/j.ahj.2024.09.029. Epub 2024 Sep 27.
3
Advancing Cardiovascular Risk Assessment with Artificial Intelligence: Opportunities and Implications in North Carolina.利用人工智能推进心血管风险评估:北卡罗来纳州的机遇与影响
N C Med J. 2024;85(1). doi: 10.18043/001c.91424. Epub 2024 Jan 10.
4
What AHRQ Learned While Working to Transform Primary Care.AHRQ 在努力推动初级保健转型过程中学到了什么。
Ann Fam Med. 2024 Mar-Apr;22(2):161-166. doi: 10.1370/afm.3090.
5
Population health interventions for cardiometabolic diseases in primary care: a scoping review and RE-AIM evaluation of current practices.基层医疗中针对心脏代谢疾病的人群健康干预措施:当前实践的范围综述和RE-AIM评估
Front Med (Lausanne). 2024 Jan 4;10:1275267. doi: 10.3389/fmed.2023.1275267. eCollection 2023.
6
Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care Practices.用于识别加拿大初级保健机构中确诊为心血管疾病患者的病例定义的验证
CJC Open. 2023 Apr 22;5(7):567-576. doi: 10.1016/j.cjco.2023.04.003. eCollection 2023 Jul.
7
Facilitating implementation of primary care mental health over time and across organizational contexts: a qualitative study of role and process.促进初级保健心理健康的实施:一项关于角色和过程的定性研究。
BMC Health Serv Res. 2023 Jun 1;23(1):565. doi: 10.1186/s12913-023-09598-y.
8
Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW.估算初级医疗保健中质量改进计划对降低心血管疾病风险的效果:来自 EvidenceNOW 的研究结果。
J Am Board Fam Med. 2023 May 8;36(3):462-476. doi: 10.3122/jabfm.2022.220331R1. Epub 2023 May 11.
9
Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association.利用实施科学促进心血管健康公平:美国心脏协会的科学声明。
Circulation. 2022 Nov 8;146(19):e260-e278. doi: 10.1161/CIR.0000000000001096. Epub 2022 Oct 10.
10
A Heart Healthy Intervention Improved Tobacco Screening Rates and Cessation Support in Primary Care Practices.一项心脏健康干预措施提高了初级保健实践中的烟草筛查率和戒烟支持率。
J Prev (2022). 2022 Jun;43(3):375-386. doi: 10.1007/s10935-022-00672-5. Epub 2022 Mar 17.

本文引用的文献

1
The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis.计算机化决策支持系统对心血管风险因素的影响:系统评价和荟萃分析。
BMC Med Inform Decis Mak. 2019 Jun 10;19(1):108. doi: 10.1186/s12911-019-0824-x.
2
"Doctor, Should I Keep Taking an Aspirin a Day?".医生,我应该继续每天服用一片阿司匹林吗?
N Engl J Med. 2019 May 16;380(20):1967-1970. doi: 10.1056/NEJMclde1903004.
3
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17.
4
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.他汀类药物依从性与动脉粥样硬化性心血管疾病患者死亡率的关系。
JAMA Cardiol. 2019 Mar 1;4(3):206-213. doi: 10.1001/jamacardio.2018.4936.
5
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.阿司匹林用于一级预防与心血管事件及出血事件的相关性:系统评价和荟萃分析。
JAMA. 2019 Jan 22;321(3):277-287. doi: 10.1001/jama.2018.20578.
6
Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials.阿司匹林用于心血管事件一级预防的疗效和安全性:随机对照试验的荟萃分析和试验序贯分析。
Eur Heart J. 2019 Feb 14;40(7):607-617. doi: 10.1093/eurheartj/ehy813.
7
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.阿司匹林对健康老年人无残疾生存的影响。
N Engl J Med. 2018 Oct 18;379(16):1499-1508. doi: 10.1056/NEJMoa1800722. Epub 2018 Sep 16.
8
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.阿司匹林用于降低心血管疾病中危患者首发血管事件风险(ARRIVE)的研究:一项随机、双盲、安慰剂对照试验。
Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26.
9
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.阿司匹林用于糖尿病患者一级预防的效果。
N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26.
10
Impact of Practice Facilitation in Primary Care on Chronic Disease Care Processes and Outcomes: a Systematic Review.基层医疗中实践促进对慢性病护理过程和结果的影响:系统评价。
J Gen Intern Med. 2018 Nov;33(11):1968-1977. doi: 10.1007/s11606-018-4581-9. Epub 2018 Jul 31.